Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

3.4K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.4K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

3.2K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
3.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K
Stem Cell Culture01:17

Stem Cell Culture

6.4K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.4K
Embryonic Stem Cells00:58

Embryonic Stem Cells

33.1K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
33.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ectomesenchyme contributes to epidermal stem cell formation through mesenchymal-to-epithelial transition.

Nature communications·2026
Same author

Safety and efficacy profile of S-005151 (Redasemtide), in patients with chronic liver diseases: phase 2 trial.

Inflammation and regeneration·2026
Same author

Intravenous high mobility group box 1 fragment improves cardiac function, fibrosis, and coronary flow in porcine ischemic cardiomyopathy model.

Scientific reports·2026
Same author

ICAM-1 and vascular matrices coordinate skin S1 macrophage formation from blood PDGFRα lineage monocyte.

Journal of leukocyte biology·2026
Same author

Characterizing stroke-related cellular changes in the surviving neurons of mouse ischemic stroke.

Neurochemistry international·2025
Same author

Identification of Keratin 5-Expressing Fibroblasts for Regenerating Keratinocytes in the Necrotic Skin Graft.

JID innovations : skin science from molecules to population health·2025

Related Experiment Video

Updated: Mar 13, 2026

Isolation and Culture of Adult Epithelial Stem Cells from Human Skin
08:26

Isolation and Culture of Adult Epithelial Stem Cells from Human Skin

Published on: March 31, 2011

29.1K

Stem Cell Therapy for Epidermolysis Bullosa-Does It Work?

Katsuto Tamai1, Jouni Uitto2

  • 1Department of Stem Cell Therapy Science, Osaka University Graduate School of Medicine, Osaka, Japan.

The Journal of Investigative Dermatology
|October 25, 2016
PubMed
Summary

Severe generalized junctional epidermolysis bullosa (JEB) shows limited success with current allogeneic stem cell therapy. Advanced strategies are needed for effective, durable treatment of this rare genetic skin disorder.

More Related Videos

Author Spotlight: Standardizing Limbal Niche Cell (LNC) Isolation and Characterization to Support Widespread LNC Research
10:11

Author Spotlight: Standardizing Limbal Niche Cell (LNC) Isolation and Characterization to Support Widespread LNC Research

Published on: October 27, 2023

1.6K
A Simplified and Efficient Method to Isolate Primary Human Keratinocytes from Adult Skin Tissue
06:17

A Simplified and Efficient Method to Isolate Primary Human Keratinocytes from Adult Skin Tissue

Published on: August 25, 2018

11.0K

Related Experiment Videos

Last Updated: Mar 13, 2026

Isolation and Culture of Adult Epithelial Stem Cells from Human Skin
08:26

Isolation and Culture of Adult Epithelial Stem Cells from Human Skin

Published on: March 31, 2011

29.1K
Author Spotlight: Standardizing Limbal Niche Cell (LNC) Isolation and Characterization to Support Widespread LNC Research
10:11

Author Spotlight: Standardizing Limbal Niche Cell (LNC) Isolation and Characterization to Support Widespread LNC Research

Published on: October 27, 2023

1.6K
A Simplified and Efficient Method to Isolate Primary Human Keratinocytes from Adult Skin Tissue
06:17

A Simplified and Efficient Method to Isolate Primary Human Keratinocytes from Adult Skin Tissue

Published on: August 25, 2018

11.0K

Area of Science:

  • Dermatology
  • Genetics
  • Regenerative Medicine

Background:

  • Epidermolysis bullosa (EB) comprises heritable skin fragility disorders with significant morbidity and mortality.
  • Caused by mutations in at least 18 genes, EB currently lacks specific and effective treatments.
  • Emerging therapeutic avenues include gene correction, protein replacement, and cell-based approaches.

Purpose of the Study:

  • To evaluate the efficacy of allogeneic stem cell therapy in patients with severe generalized junctional epidermolysis bullosa.
  • To review current literature on cell-based therapies for epidermolysis bullosa.
  • To identify needs for advanced therapeutic strategies for intractable EB disorders.

Main Methods:

  • Case report of two patients with severe generalized JEB treated with allogeneic stem cell therapy.
  • Literature review of existing cell-based therapeutic approaches for EB.
  • Analysis of treatment outcomes and identification of limitations.

Main Results:

  • Allogeneic stem cell therapy demonstrated limited success in the two reported patients with severe generalized JEB.
  • Current cell-based therapies may offer symptomatic relief but not a durable cure.
  • Existing strategies highlight the need for improved safety and efficacy.

Conclusions:

  • Allogeneic stem cell therapy shows minimal efficacy for severe generalized JEB.
  • Current cell-based treatments offer only partial amelioration of EB symptoms.
  • Development of advanced, safer therapeutic strategies is crucial for intractable EB.